Psomagen

소마젠 · 950200

Industrials Commercial Services · KOSDAQ

Small-cap

Market cap US$39.6M (₩54.6B)

Overview

Psomagen provides genomic sequencing and genetic analysis services, laboratory work that reads and interprets DNA to support research, diagnostics, and life-science applications.

Its services are used by researchers, healthcare institutions, and biotechnology companies. Listed on KOSDAQ, South Korea's technology and small-cap exchange, the company operates in a field where the underlying filing text does not specify a single dominant product line or structural shift.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$30.2K

▲ +30.0% YoY

Operating profit · FY2025

−US$1.1K

Loss narrowed

Net income · FY2025

−US$2.1K

Loss narrowed

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$17.9K(₩24.7M)	US$23.2K(₩32M)	US$30.2K(₩41.6M)
Operating profit	−US$2K(−₩2.7M)	−US$2.8K(−₩3.8M)	−US$1.1K(−₩1.6M)
Net income	−US$2.4K(−₩3.4M)	−US$3.3K(−₩4.6M)	−US$2.1K(−₩2.9M)

Revenue

FY2023US$17.9K
FY2024US$23.2K
FY2025US$30.2K

Operating profit

FY2023−US$2K
FY2024−US$2.8K
FY2025−US$1.1K

Net income

FY2023−US$2.4K
FY2024−US$3.3K
FY2025−US$2.1K

Key ratios (FY2025)

ROE

-16.2%

Debt/Eq

93.6%

Op. margin

-3.8%

Net margin

-7.0%

Rev. YoY

▲ +30.0%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?